Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(18%)
Results Posted
40%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
13
76%
Ph phase_1
1
6%
Ph early_phase_1
3
18%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
3(17.6%)
Phase 1Safety & dosage
1(5.9%)
N/ANon-phased studies
13(76.5%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)
Other(6)

Detailed Status

unknown5
Completed5
Recruiting2
Not yet recruiting1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
83.3%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 13 (17.6%)
Phase 11 (5.9%)
N/A13 (76.5%)

Trials by Status

unknown529%
not_yet_recruiting16%
active_not_recruiting16%
completed529%
withdrawn16%
terminated16%
recruiting212%
suspended16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT06881472Not Applicable

The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes

Completed
NCT03493178Early Phase 1

Glutathione in Mild Cognitive Impairment

Active Not Recruiting
NCT07350512Not Applicable

Investigating the Acute Effects of Increasing Alanine Exposure in Healthy Participants

Not Yet Recruiting
NCT04740580Early Phase 1

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

Recruiting
NCT06579391Not Applicable

Targeted Nutritional Supplement After Lumbar Spine Surgery: A Randomized, Placebo-Controlled, Double-Blind Trial

Withdrawn
NCT04703036Early Phase 1

Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19

Terminated
NCT06419686Phase 1

The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals

Recruiting
NCT03566524Not Applicable

Study of Arginine and Nitric Oxide in Patients With Diabetes

Completed
NCT01185210Not Applicable

Investigation of Alanine in Fructose Intolerance: A Dose Ranging Study

Unknown
NCT04022434Not Applicable

Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance

Unknown
NCT00968344Not Applicable

Muscle Mass During Space Exploration

Completed
NCT01922167Not Applicable

Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women

Completed
NCT03180775Not Applicable

Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity

Unknown
NCT00760383Not Applicable

Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation

Completed
NCT01496768Not Applicable

Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects

Suspended
NCT01239303Not Applicable

Effects of Citrulline on Gut Functioning During Excercise

Unknown
NCT00005889Not Applicable

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17